Introduction of PandaOmics for Target Discovery in Amyotrophic Lateral Sclerosis patients

Insilico Medicine introduces the use of AI-based platform, PandaOmics, for target discovery in Amyotrophic Lateral Sclerosis (ALS) patients.
To read more about the story, please visit: als.ai
Follow us on LinkedIn: / pandaomics
For more information about the platform visit: insilico.com/p...

[@md.shayadhossain3551]

Nice video

[@musicvideo1566]

very nice

[@baharkarimi5845]

Hello.I wish you good health,I want to know how this beautiful science can be learned online?🌿🌿

[@anikaamma8366]

Nice video bro I just got home from work is

[@mkhumayunkabir1272]

vary good

[@farukahmed7263]

Wonderful

[@surayaibrahim1164]

Beautiful

[@sazzadrahaman3436]

Nice vedeio

[@mdmohidulislam2487]

Good

[@kamrulislam1651]

Nice ❤️😳🙈

[@shorifulislam4473]

Nice

[@kamrultelecom7901]

Nice 🙂🙂🙂🙂 to

[@merajhossain4715]

Great

[@rsanupom3061]

Joss video

[@asikulislam3585]

work

[@mdborhan2690]

very good

[@palashhossain2989]

very nice